Evidence method
Level · gp.fundamentals.capex_revenue_ratio
38.91% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WVE · Jun 30, 2026
Wave Life Sciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-324949General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2358.36% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-73.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-3248.33% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2257.61% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
472.40% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History6 statesHistory building
Period transition
What moved in the state?
- Previous
- 1.15%
- Current
- 38.91%
- Delta
- 37.76%
- Previous
- -155.71%
- Current
- -2358.36%
- Delta
- -2202.65%
- Previous
- 316.85%
- Current
- -73.88%
- Delta
- -390.73%
- Previous
- -81.83%
- Current
- -3248.33%
- Delta
- -3166.49%
- Previous
- 124.04%
- Current
- 2257.61%
- Delta
- 2133.58%
- Previous
- 23.70%
- Current
- 472.40%
- Delta
- 448.71%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Wave Life Sciences, Inc. →Transitioned To · WVE Fundamental State →Transitioned To · WVE CAPEX_INTENSITY_INCREASED →Transitioned To · WVE CASH_GENERATION_DECREASED →Transitioned To · WVE GROWTH_DECREASED →Transitioned To · WVE PROFITABILITY_DECREASED →Transitioned To · WVE R_AND_D_INTENSITY_INCREASED →Transitioned To · WVE SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.